INBX250221C00025000 Option on Inhibrx

INBX Stock  USD 15.08  0.18  1.18%   

Inhibrx Total Stockholder Equity

Total Stockholder Equity

45.68 Million

At this time, Inhibrx's Total Stockholder Equity is fairly stable compared to the past year.

Inhibrx Corporate Management

Leah JDCorporate VPProfile
Mark LappeChairman, FounderProfile
Charbel PharmDVice PlanningProfile
BS CPAChief OfficerProfile
Jeffrey JensenExecutive OfficerProfile
Brendan EckelmanExecutive OfficerProfile
Carlos BaisExecutive SciencesProfile

Additional Tools for Inhibrx Stock Analysis

When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.